These effects are temporary and typically resolve quickly
It is not a therapeutic product, nor are any claims made regarding its biological effects in humans or animals
Don't forget the essentials GHK-Cu (Glycyl-L-Histidyl-L-Lysine, Cu2+ copper complex) is a tripeptide of 340 Da free, 403 Da complexed with copper, discovered by Loren Pickart in 1973 at the University of San Francisco
The DARS (dopamine augmented rehabilitation in stroke) trial: protocol for a randomised controlled trial of co-careldopa treatment in addition to routine NHS occupational and physical therapy after stroke
Factors Underlying Differences Between Fibroblast Growth Factor 21 Analogs While LY2405319 (244), PF-05231023 (183), efruxifermin (246), BFKB8488A (301), and MK-3655 (303) were observed to ameliorate dyslipidemia, with strong reductions in triglycerides and increases in HDL-cholesterol, only efruxifermin and MK-3655 have so far demonstrated the potential to increase insulin sensitivity and to improve glycemic control
Cel Death Dis 12 (8), 782